Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 314

Sort by

Sort Order Select

Journal Articles

CD27 is required for protective lytic EBV antigen–specific CD8 + T-cell expansion

Yun Deng, Bithi Chatterjee, Kyra Zens, Hana Zdimerova, Anne Müller, Patrick Schuhmachers, Laure-Anne Ligeon, Antonino Bongiovanni, Riccarda Capaul, Andrea Zbinden, Angelika Holler, Hans Stauss, Wolfgang Hammerschmidt, Christian Münz

Blood (2021) 137 (23): 3225–3236.

https://doi.org/10.1182/blood.2020009482

Published: 2021

Includes: Supplemental data

Journal Articles

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults

Pengpeng Liu, Xiangyu Pan, Chong Chen, Ting Niu, Xiao Shuai, Jian Wang, Xuelan Chen, Jiazhuo Liu, Yong Guo, Liping Xie, Yu Wu, Yu Liu, Ting Liu

Blood (2020) 135 (11): 826–833.

https://doi.org/10.1182/blood.2019003886

Published: 2020

Includes: Supplemental data

Journal Articles

Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection

Stuart G. Tangye, Sylvain Latour

Blood (2020) 135 (9): 644–655.

https://doi.org/10.1182/blood.2019000928

Published: 2020

Journal Articles

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Ethel Cesarman, MD PhD, Mikhail Roshal, MD PhD, Jonathan Reichel, PhD, Wagner Florian, PhD, Bhavneet Binder, Sakellarios Zairis, Jouliana Sadek, PhD, Joshua Brody, MD, Raul Rabadan, PhD, Sandeep Dave, MD

Blood (2019) 134 (Supplement_1): 549.

https://doi.org/10.1182/blood-2019-131163

Published: 2019

Journal Articles

Gastrointestinal Plasmoblastic Lymphoma Associated with Wiskott-Aldrich Syndrome: A Case Report

Ali Unal, MD, Serhat Çelik, Zeynep Güven, MD, Leylagul Kaynar, MD, Bulent Eser, MD, Mustafa Çetin

Blood (2019) 134 (Supplement_1): 5359.

https://doi.org/10.1182/blood-2019-123387

Published: 2019

Journal Articles

A Clinically-Indolent Variant of Extranodal NK/T Cell Lymphoma with Unique Immunophenotypic Profile and Superior Outcome

Fabiola Valvert, MD, Elizabeth Solorzano, MSc, Edward Briercheck, MD, Marcos Mauricio Siliézar Tala, MD, Yasodha Natkunam, MD PhD, David M. Weinstock, MD, Oscar Silva, MD PhD

Blood (2019) 134 (Supplement_1): 5278.

https://doi.org/10.1182/blood-2019-131620

Published: 2019

Journal Articles

Interactome Analysis of APOBEC3B in Multiple Myeloma

Yasuhiro Kazuma, MD, Kotaro Shirakawa, MD PhD, Anamaria Daniela Sarca, MD, Yoshihito Horisawa, MD, Hirofumi Fukuda, MD, Hiroyuki Matsui, MD, Hiroyuki Yamazaki, MD, Tadahiko Matsumoto, MD, Fumiko Tanabe, Ryo Morishita, PhD, Shinji Ito, PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 1259.

https://doi.org/10.1182/blood-2019-126856

Published: 2019

Journal Articles

Burden of Hospitalizations Due to Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV + PTLD) in Patients Who Failed First Line Rituximab or Rituximab Plus Chemotherapy Following Solid Organ Transplant (Post-SOT): A Retrospective Chart Review Study of German PTLD Registry

Heiner Zimmermann, MD, Hairong Xu, MD PhD, Arie Barlev, PharmD, Yang Zhang, PhD, Dhanalakshmi Thirumalai, Crystal Watson, MS, Ralf Ulrich Trappe, MD

Blood (2019) 134 (Supplement_1): 65.

https://doi.org/10.1182/blood-2019-124583

Published: 2019

Journal Articles

Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders

Blood (2019) 134 (Supplement_1): 83.

https://doi.org/10.1182/blood-2019-131884

Published: 2019

Journal Articles

Cell of Origin and Treatment Impact on the Outcome of Monomorphic Post-Transplant Lymphoproliferative Disorder-Diffuse Large B-Cell Lymphoma Subtype

Francesca Montanari, MD, Changchun Deng, MD PhD, Ahmed Sawas, MD, Jennifer Kimberly Lue, MD, Enrica Marchi, MD, PhD, Dejan Radeski, MBBS, FRACP, FRCPA, Bin Cheng, PhD, Govind Bhagat, MD, Owen A. O'Connor, MD PhD

Blood (2019) 134 (Supplement_1): 2909.

https://doi.org/10.1182/blood-2019-131841

Published: 2019

Journal Articles

Gene Editing and mRNA-Based Therapy: Two Complementary Therapeutic Approaches for the Treatment of Patients with Xmen Disease

Julie Brault, PhD PharmD, Ezekiel Bello, Ronald J. Meis, PhD, Taylor Liu, Sherry M. Koontz, BS, Kennichi Dowdell, PhD, Linhong Li, PhD, Cornell Allen, MS, Narda Theobald, BS, Janet Lee, BS, Aaron B. Clark, BS, Juan C. Ravell, MD, Michael Lenardo, MD, Gary A. Dahl, PhD, Harry L. Malech, MD, Suk See De Ravin, MD, PhD

Blood (2019) 134 (Supplement_1): 4637.

https://doi.org/10.1182/blood-2019-129062

Published: 2019

Journal Articles

Say hello to TUGSE!

Kyle T. Wright, Olga Pozdnyakova

Blood (2019) 134 (16): 1360.

https://doi.org/10.1182/blood.2019002505

Published: 2019

Journal Articles

Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma

Linda von Hoff, Eva Kärgel, Vedran Franke, Erik McShane, Kathrin W. Schulz-Beiss, Giannino Patone, Nikolai Schleussner, Marina Kolesnichenko, Norbert Hübner, Oliver Daumke, Matthias Selbach, Altuna Akalin, Stephan Mathas, Claus Scheidereit

Blood (2019) 133 (13): 1489–1494.

https://doi.org/10.1182/blood-2018-08-871293

Published: 2019

Includes: Supplemental data

Journal Articles

Clonal T-Large Granular Lymphocyte Proliferations in Childhood: Friend or Foe?

Sureyya Savasan, MD, Batool Al-Qanber, MD, Steven Buck, MS, Erin Wakeling, PhD, Manisha Gadgeel, MBBS, MS

Blood (2018) 132 (Supplement 1): 3719.

https://doi.org/10.1182/blood-2018-99-119124

Published: 2018

Journal Articles

Clinical and Genetic Features of Epstein-Barr Virus-Triggered Late-Onset Primary Hemophagocytic Lymphohistiocytosis: 10 Pedigrees Study

Chunrui Li, MD PhD, Lili Gao, Li Yang, Min Xiao, MD PhD, Jianfeng Zhou, MD PhD, Yicheng Zhang, MD PhD

Blood (2018) 132 (Supplement 1): 3903.

https://doi.org/10.1182/blood-2018-99-114009

Published: 2018

Journal Articles

Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results from a Phase 1 Study

Blood (2018) 132 (Supplement 1): 399.

https://doi.org/10.1182/blood-2018-99-118344

Published: 2018

Journal Articles

Inflammatory Bowel Disease and Hodgkin's Lymphoma: Two New Observations

Zoubida Tazi Mezalek, MD, Myriam Bourkia, Sofia Habib Allah, Noha Al Waragli, Majdouline Bouaouad, Amina Lhoussni, MD, Hajar Khibri, Wafaa Ammouri, Mouna Maamar, Hicham Harmouche, Mohammed Adnaoui

Blood (2018) 132 (Supplement 1): 5353.

https://doi.org/10.1182/blood-2018-99-110615

Published: 2018

Journal Articles

Pembrolizumab Therapy Exacerbates EBV-Induced Infections and Tumors in a Long-Term Fully Humanized Mouse Model

Renata Stripecke, Prof., Simon Danisch, PhD, Constanze Slabik, Reinhard Zeidler, Prof., Wolfgang Hammerschmidt, Prof., Friedrich Feuerhake, Arnold Ganser, MD

Blood (2018) 132 (Supplement 1): 2405.

https://doi.org/10.1182/blood-2018-99-111693

Published: 2018

Journal Articles

BZLF1-DEC205 Fusion Protein Enhances EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

Elshafa Hassan Ahmed, DVM, Eric Brooks, Shelby Sloan, BS, Sarah Schlotter, Frankie Jeney, Charlene Mao, Polina Shindiapina, MD PhD, Salma Shire, Claire Hale, Manjusri Das, Alexander Prouty, Michael A. Caligiuri, MD, Robert A Baiocchi, MD PhD

Blood (2018) 132 (Supplement 1): 342.

https://doi.org/10.1182/blood-2018-99-117837

Published: 2018

Journal Articles

The Outcomes of Epstein-Barr Virus Specific T Cells from Different Sources for EBV Infections in Recipients of Allogeneic Stem Cell Transplantation

Ren Lin, Fen Huang, Zhiping Fan, Xiaoyan Shao, Guoxian Dai, Na Xu, PhD, Li Xuan, Jieyu Ye, Jing Sun, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 3330.

https://doi.org/10.1182/blood-2018-99-116010

Published: 2018

NARROW

CD27 is required for protective lytic EBV antigen–specific CD8 + T-cell expansion

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults

Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Gastrointestinal Plasmoblastic Lymphoma Associated with Wiskott-Aldrich Syndrome: A Case Report

A Clinically-Indolent Variant of Extranodal NK/T Cell Lymphoma with Unique Immunophenotypic Profile and Superior Outcome

Interactome Analysis of APOBEC3B in Multiple Myeloma

Burden of Hospitalizations Due to Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV + PTLD) in Patients Who Failed First Line Rituximab or Rituximab Plus Chemotherapy Following Solid Organ Transplant (Post-SOT): A Retrospective Chart Review Study of German PTLD Registry

Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders

Cell of Origin and Treatment Impact on the Outcome of Monomorphic Post-Transplant Lymphoproliferative Disorder-Diffuse Large B-Cell Lymphoma Subtype

Gene Editing and mRNA-Based Therapy: Two Complementary Therapeutic Approaches for the Treatment of Patients with Xmen Disease

Say hello to TUGSE!

Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma

Clonal T-Large Granular Lymphocyte Proliferations in Childhood: Friend or Foe?

Clinical and Genetic Features of Epstein-Barr Virus-Triggered Late-Onset Primary Hemophagocytic Lymphohistiocytosis: 10 Pedigrees Study

Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results from a Phase 1 Study

Inflammatory Bowel Disease and Hodgkin's Lymphoma: Two New Observations

Pembrolizumab Therapy Exacerbates EBV-Induced Infections and Tumors in a Long-Term Fully Humanized Mouse Model

BZLF1-DEC205 Fusion Protein Enhances EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

The Outcomes of Epstein-Barr Virus Specific T Cells from Different Sources for EBV Infections in Recipients of Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only